awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36058025-1CDD8B8C-9B44-4B8E-8A27-184D57C4D400
Q36058025-1CDD8B8C-9B44-4B8E-8A27-184D57C4D400
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36058025-1CDD8B8C-9B44-4B8E-8A27-184D57C4D400
Trelagliptin (SYR-472, Zafatek), Novel Once-Weekly Treatment for Type 2 Diabetes, Inhibits Dipeptidyl Peptidase-4 (DPP-4) via a Non-Covalent Mechanism.
P2860
Q36058025-1CDD8B8C-9B44-4B8E-8A27-184D57C4D400
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36058025-1CDD8B8C-9B44-4B8E-8A27-184D57C4D400
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0d9a0955938fa54c7c17d35528bfcd2fd17591c4
P2860
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes